Company intelligence / Profile preview
Easywell Biomedicals
- Ownership
- Private
- Development stage
- Other
Overview
Easywell Biomedicals is a Taiwan-based healthcare company active in pharmaceuticals, regenerative medicine, and medical devices. The company develops and commercializes active pharmaceutical ingredients, dosage-form pharmaceuticals, and medical products, and operates U.S. pharmaceutical development and cGMP manufacturing through its Tulex subsidiary. Its disclosed pipeline includes 505(b)(2) reformulations, high-barrier generics, and marketed products such as HH-001 sacubitril/valsartan tablets in China. Easywell also highlights proprietary formulation and drug-delivery technologies focused on bioavailability enhancement and programmable release profiles. The company is publicly traded in Taiwan under stock code 1799 and appears to be expanding through partnerships, licensing, and share-swap M&A activity.
- Therapeutic areas
- ImmunologyCardiovascularEndocrinologyNeurologyRare DiseasesPsychiatry
- Modalities
- Small moleculeDeviceCell therapyDrug delivery therapyTransdermal patchModified-release oral dosage formOral liquid extended-release formulation
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Easywell Biomedicals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Easywell Biomedicals.